EVERQUOTE INC

EverQuote insiders sell shares amid bullish rally – learn why the 10b5‑1 trades matter for investors and how they signal future price trends.

CEO Jayme Mendal’s disciplined 10b5‑1 buy‑sell on EverQuote signals strategic rebalancing, not distress—insight for long‑term investors.

Shields John L. sells 3,126 EverQuote shares under his 10‑b5‑1 plan, generating $73k while maintaining a disciplined liquidity strategy and reassuring investors.

Sanborn Joseph’s 10b5‑1 sale of 6,667 EverQuote shares shows routine insider liquidity management, not a warning, amid solid growth and market stability.

EverQuote insider sales: July 1, 2026 shows top execs off‑loading shares at market‑aligned prices, sparking questions about confidence and future growth.

EverQuote insider sales: Jon Ayotte’s 888‑share Rule 10b‑5‑1 sell shows routine liquidity, strong holdings, and stable fundamentals—no sign of a downturn.

EverQuote CFO’s 20k‑share sale under a Rule 10b5‑1 plan shows a routine portfolio move, not a red flag, while the stock’s 41% weekly rise and strong fundamentals keep its growth trajectory intact.

EverQuote CTO’s $7.10 buy signals bullish confidence while top execs sell—mixed insider moves hint at future upside, but liquidity worries loom.

EverQuote insider sale: director Neble George R. sells 670 shares under a Rule 10b5‑1 plan, amid rising buzz and price decline—what it means for investors.

EverQuote insider sales spike: CAO Ayotte Jon sells 364 shares under a Rule 10b5‑1 plan, raising concerns about company confidence and investor risk.